STS 2024食管切除术短期风险模型更新:更包容、校准更优
基于STS-GTSD 2015–2022年254中心18503例食管癌切除术患者,更新手术死亡、重大并发症及复合结局三个风险模型。新模型纳入体表面积和保险支付方类型等预测因子,整体区分度与既往模型相似或更优,校准在各亚组均良好。
要点
- 更新模型纳入体表面积和保险支付方类型等新预测因子。
- 手术死亡率3.4%,重大并发症率30.5%,复合结局率30.9%。
- 新模型区分度与既往模型相似或更优,各亚组校准良好。
核心结论
- 新食管切除术风险模型性能与既往模型相似或更优,适用性更广且具有临床表面效度。
主要发现
- 共纳入254中心18503例患者,手术死亡率3.4%、重大并发症率30.5%、复合结局率30.9%。
- 新模型纳入体表面积和保险支付方类型作为短期结局的新预测因子。
- 整体区分度:手术死亡C统计量0.72,复合结局C统计量0.62,与既往模型相似或更优。
- 模型区分度在手术方式和人口学亚组间可比,校准在所有患者亚组中均优。
临床怎么用
- 新模型可提供稳健的术前风险评估,用于共享决策、提供者绩效评估和质量改进。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Society of Thoracic Surgeons General Thoracic Surgery Database (STS-GTSD) previously reported short-term risk models for esophagectomy for esophageal cancer. We sought to update existing models using more inclusive contemporary cohorts, with consideration of additional risk factors based on clinical evidence. METHODS: The study population consisted of adult patients in the STS-GTSD who underwent esophagectomy for esophageal cancer between January 2015 and December 2022. Separate esophagectomy risk models were derived for 3 primary end points: operative mortality, major morbidity, and composite morbidity or mortality. Logistic regression with backward selection was used, with predictors retained in models if P < .10. All derived models were validated using 9-fold cross-validation. Model discrimination and calibration were assessed for the overall cohort and specified subgroups. RESULTS: A total of 18,503 patients from 254 centers underwent esophagectomy for esophageal cancer. Operative mortality, morbidity, and composite morbidity or mortality rates were 3.4%, 30.5%, and 30.9%, respectively. Novel predictors of short-term outcomes in the updated models included body surface area and insurance payor type. Overall discrimination was similar or superior to previous STS-GTSD models for operative mortality (C statistic = 0.72) and for composite morbidity or mortality (C statistic = 0.62), Model discrimination was comparable across procedure- and demographic-specific subcohorts. Model calibration was excellent in all patient subgroups. CONCLUSIONS: The newly derived esophagectomy risk models showed similar or superior performance compared with previous models, with broader applicability and clinical face validity. These models provide robust preoperative risk estimation and can be used for shared decision making, assessment of provider performance, and quality improvement.
引用
- Velotta JB, Seder CW, Bonnell LN, et al. 2024 Update of The Society of Thoracic Surgeons Short-term Esophagectomy Risk Model: More Inclusive and Improved Calibration. Ann Thorac Surg. 2024. PMID: 38950724. doi:10.1016/j.athoracsur.2024.05.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。